Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Early detection through regular retinal photography can identify changes before symptoms develop and prevent vision loss
A synthetic 31-amino acid C18 fatty diacid-conjugated GLP-1 analogue and the most extensively characterised long-acting selective glucagon-like peptide-1 receptor agonist research compound available to laboratories in Ireland and a structurally optimised GLP-1(7-37) analogue incorporating Aib8 substitution for DPP-IV resistance, Arg34Lys substitution eliminating a proteolytic site, and a C18 fatty diacid conjugated via a hydrophilic linker to Lys26 enabling tight reversible albumin binding that produces a circulating half-life of about one week and once-weekly pharmacokinetics activating the GLP-1 receptor through canonical Gs-cAMP-PKA-EPAC2 signal transduction in pancreatic beta cells, hypothalamic appetite-regulating nuclei, brainstem nucleus tractus solitarius, cardiac tissue, and peripheral organs to produce glucose-stimulated insulin secretion potentiation, glucagon suppression, gastric emptying inhibition, pronounced central appetite suppression and body weight reduction, beta cell trophic biology, and cardioprotective signalling
Once-weekly injection for convenient dosing
Self-reported community sources describe: Injection-site reactions rising with consecutive same-site injections
The FDA maintains a list of tainted weight loss products that contain active drug ingredients not listed on product labelspotentially interacting with medications or supplements youre already taking
US$ 20.93
US$ 26.80
US$ 26.81
US$ 29.96
US$ 20.43
US$ 29.52
